Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis-Reference-Cited by-同舟云学术

Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis

Published:2012-02-07 Issue:8 Volume:109 Page:3018-3023
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Feng H.,Hu B.,Jarzynka M. J.,Li Y.,Keezer S.,Johns T. G.,Tang C. K.,Hamilton R. L.,Vuori K.,Nishikawa R.,Sarkaria J. N.,Fenton T.,Cheng T.,Furnari F. B.,Cavenee W. K.,Cheng S.-Y.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference20 articles.

1. Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma

2. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

3. Malignant astrocytic glioma: genetics, biology, and paths to treatment

4. Oncogenic EGFR Signaling Networks in Glioma

5. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specificity of U2 and GOL1 aptamers to EGFR-positive human glioblastoma cells in vitro;Журнал высшей нервной деятельности им. И.П. Павлова;2024-07-10

2. Specificity of Aptamers U2 and Gol1 to EGFR-Positive Human Glioblastoma Cells in Vitro;Neuroscience and Behavioral Physiology;2024-07

3. Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms;International Journal of Molecular Sciences;2024-06-19

4. Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes;EPMA Journal;2023-12-06

5. DOCK1 insufficiency disrupts trophoblast function and pregnancy outcomes via DUSP4-ERK pathway;Life Science Alliance;2023-11-15